PPP1R2
Protein phosphatase inhibitor 2
Also known as: IPP2, IPP2_HUMAN, PPP1R2A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P41236
- Gene
- PPP1R2
- Ensembl
- ENSG00000184203
- Chromosome
- 3
- Canonical length
- 205 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Protein phosphatase-1 (PP1) is one of the main eukaryotic serine/threonine phosphatases. The protein encoded by this gene binds to the catalytic subunit of PP1, strongly inhibiting its activity. Ten related pseudogenes have been found throughout the human genome. Several splice variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Canonical amino-acid sequenceUniProt
205 residues, UniProt reviewed canonical sequence.
>P41236|PPP1R2
1 MAASTASHRP IKGILKNKTS TTSSMVASAE QPRGNVDEEL SKKSQKWDEM NILATYHPAD
61 KDYGLMKIDE PSTPYHSMMG DDEDACSDTE ATEAMAPDIL ARKLAAAEGL EPKYRIQEQE
121 SSGEEDSDLS PEEREKKRQF EMKRKLHYNE GLNIKLARQL ISKDLHDDDE DEEMLETADG
181 ESMNTEESNQ GSTPSDQQQN KLRSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPP1R2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 80 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 80 nTPM
- bone marrow: 64 nTPM
- tongue: 53 nTPM
- lymph node: 27 nTPM
- testis: 27 nTPM
- thymus: 26 nTPM
Single-cell type
- esophageal apical cells: 505 nCPM
- late primary spermatocytes: 466 nCPM
- lymphatic endothelial cells: 328 nCPM
- t-cells: 309 nCPM
- neutrophils: 299 nCPM
- early spermatids: 249 nCPM
Immune cell
- eosinophil: 258 nTPM
- naive CD4 T-cell: 179 nTPM
- T-reg: 169 nTPM
- neutrophil: 153 nTPM
- memory CD4 T-cell: 150 nTPM
- total PBMC: 129 nTPM
Brain region
- hypothalamus: 45 nTPM
- pons: 37 nTPM
- choroid plexus: 35 nTPM
- hippocampal formation: 35 nTPM
- cerebral cortex: 35 nTPM
- basal ganglia: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.57
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- generation of precursor metabolites and energy
- glycogen metabolic process
- intracellular signal transduction
- regulation of signal transduction
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPP1R2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPP1R2 as an antibody target. Whether an autoantibody or antibody against PPP1R2 could matter depends on whether native PPP1R2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPP1R2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPP1R2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...